http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011074092-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6107abcc76ad54b3821249d6315e0ab |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
filingDate | 2011-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70886cf312deb7da0e09aeab8d3beb1d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58415b4490b485e5b7c66f6546e84e79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6fbe2916f50415c5614a9bbedc8c635 |
publicationDate | 2011-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2011074092-A |
titleOfInvention | Ophthalmic composition |
abstract | The present invention provides an ophthalmic composition in which a cooling action at an application site is enhanced and initial irritation at the time of application is suppressed. In an ophthalmic composition, A) a monocyclic monoterpenoid and B) a monoterpene alcohol are blended within a range of 0.01 to 2000 parts by weight of B) to 1 part by weight of A). As a result, the surface temperature at the application site is lowered or the cooling effect is sustained, so that the cooling effect is enhanced, while the initial irritation at the time of application is suppressed, and the ophthalmic use with excellent sensory characteristics It can be a composition. [Selection figure] None |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113423428-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020184479-A1 |
priorityDate | 2003-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 440.